AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2021
Jun 17, 2021
31523_dirs_2021-06-17_7dc61eea-a307-4789-8925-31b322468d03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-06-15
Reporting Person: Crowley John F (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-15 | Common Stock | M | 22000 | $4.38 | Acquired | 899230 | Direct |
| 2021-06-15 | Common Stock | S | 22000 | $10.256 | Disposed | 877230 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Stock Options (right to buy) | $4.38 | M | 22000 | Disposed | 2022-06-04 | Common Stock (22000) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $11.19 | G | 230000 | Disposed | 2025-01-02 | Common Stock (230000) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $15.96 | G | 230000 | Disposed | 2025-06-01 | Common Stock (230000) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $11.74 | G | 250000 | Disposed | 2026-01-04 | Common Stock (250000) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $5.13 | G | 6889 | Disposed | 2027-01-03 | Common Stock (6889) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $15.67 | G | 131580 | Disposed | 2028-01-03 | Common Stock (131580) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $10.04 | G | 216351 | Disposed | 2029-01-02 | Common Stock (216351) | Direct |
| 2021-06-16 | Stock Options (right to buy) | $9.55 | G | 142872 | Disposed | 2030-01-02 | Common Stock (142872) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64895 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.13 to $10.69 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: All of these options were fully vested and exercisable as of the transaction date.
F4: The gift of vested options reported on this Form 4 were made to the John F. Crowley 2021 Family Trust for the benefit of the reporting person's children. The reporting person's spouse is a trustee of the trust.